Quantcast

Latest PGL4001 Stories

2008-08-19 09:00:16

PregLem has started an international Phase III clinical trial program for PGL4001 in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. The program is composed of two separate Phase III clinical trials involving a total of 540 patients and being carried out in parallel in a total of 14 countries. Results of the Phase III trials are expected in 2010. The first trial (Pearl I) is a randomized, parallel group, double-blind,...

2008-08-19 03:00:13

Geneva, Switzerland, 19 August 2008 - PregLem SA, a Swiss biopharmaceutical company specialized in reproductive medicine, today announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. PGL4001, an orally active, selective progesterone receptor modulator, was shown in a previous Phase II study to be well...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.